1014 related articles for article (PubMed ID: 29052277)
21. ZEB1 and ZEB2 transcription factors are potential therapeutic targets of canine mammary cancer cells.
Xavier PLP; Cordeiro YG; Rochetti AL; Sangalli JR; Zuccari DAPC; Silveira JC; Bressan FF; Fukumasu H
Vet Comp Oncol; 2018 Dec; 16(4):596-605. PubMed ID: 30047225
[TBL] [Abstract][Full Text] [Related]
22. Akt activation is responsible for enhanced migratory and invasive behavior of arsenic-transformed human bronchial epithelial cells.
Wang Z; Yang J; Fisher T; Xiao H; Jiang Y; Yang C
Environ Health Perspect; 2012 Jan; 120(1):92-7. PubMed ID: 21954225
[TBL] [Abstract][Full Text] [Related]
23. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR.
Du F; Qiao C; Li X; Chen Z; Liu H; Wu S; Hu S; Qiu Z; Qian M; Tian D; Wu K; Fan D; Nie Y; Xia L
Theranostics; 2019; 9(13):3879-3902. PubMed ID: 31281520
[No Abstract] [Full Text] [Related]
24. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway.
Xue M; Pang H; Li X; Li H; Pan J; Chen W
Cancer Sci; 2016 Jan; 107(1):18-27. PubMed ID: 26544536
[TBL] [Abstract][Full Text] [Related]
25. SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR-150.
Barbáchano A; Fernández-Barral A; Pereira F; Segura MF; Ordóñez-Morán P; Carrillo-de Santa Pau E; González-Sancho JM; Hanniford D; Martínez N; Costales-Carrera A; Real FX; Pálmer HG; Rojas JM; Hernando E; Muñoz A
Oncogene; 2016 Jun; 35(23):2991-3003. PubMed ID: 26455323
[TBL] [Abstract][Full Text] [Related]
26. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
Qiu G; Lin Y; Zhang H; Wu D
Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
[TBL] [Abstract][Full Text] [Related]
27. Ets1 and ESE1 reciprocally regulate expression of ZEB1/ZEB2, dependent on ERK1/2 activity, in breast cancer cells.
Sinh ND; Endo K; Miyazawa K; Saitoh M
Cancer Sci; 2017 May; 108(5):952-960. PubMed ID: 28247944
[TBL] [Abstract][Full Text] [Related]
28. Role of miR-200c/miR-141 in the regulation of epithelial-mesenchymal transition and migration in head and neck squamous cell carcinoma.
Tamagawa S; Beder LB; Hotomi M; Gunduz M; Yata K; Grenman R; Yamanaka N
Int J Mol Med; 2014 Apr; 33(4):879-86. PubMed ID: 24424572
[TBL] [Abstract][Full Text] [Related]
29. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
[TBL] [Abstract][Full Text] [Related]
30. Snail regulated by PKC/GSK-3β pathway is crucial for EGF-induced epithelial-mesenchymal transition (EMT) of cancer cells.
Liu ZC; Chen XH; Song HX; Wang HS; Zhang G; Wang H; Chen DY; Fang R; Liu H; Cai SH; Du J
Cell Tissue Res; 2014 Nov; 358(2):491-502. PubMed ID: 25124796
[TBL] [Abstract][Full Text] [Related]
31. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control.
Grassi ML; Palma CS; Thomé CH; Lanfredi GP; Poersch A; Faça VM
J Proteomics; 2017 Jan; 151():2-11. PubMed ID: 27394697
[TBL] [Abstract][Full Text] [Related]
32. MicroRNAs Associated with Epithelial-Mesenchymal Transition Can Be Targeted to Inhibit Peritoneal Dissemination of Human Scirrhous Gastric Cancers.
Takei Y; Shen G; Morita-Kondo A; Hara T; Mihara K; Yanagihara K
Pathobiology; 2018; 85(4):232-246. PubMed ID: 29847827
[TBL] [Abstract][Full Text] [Related]
33. ETS1 is coexpressed with ZEB2 and mediates ZEB2-induced epithelial-mesenchymal transition in human tumors.
Yalim-Camci I; Balcik-Ercin P; Cetin M; Odabas G; Tokay N; Sayan AE; Yagci T
Mol Carcinog; 2019 Jun; 58(6):1068-1081. PubMed ID: 30790340
[TBL] [Abstract][Full Text] [Related]
34. Akt and Notch pathways mediate polyhexamethylene guanidine phosphate-induced epithelial-mesenchymal transition via ZEB2.
Jeong MH; Kim HR; Park YJ; Chung KH
Toxicol Appl Pharmacol; 2019 Oct; 380():114691. PubMed ID: 31348943
[TBL] [Abstract][Full Text] [Related]
35. F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT.
Sun C; Tao Y; Gao Y; Xia Y; Liu Y; Wang G; Gu Y
Biomed Pharmacother; 2018 Feb; 98():416-423. PubMed ID: 29278851
[TBL] [Abstract][Full Text] [Related]
36. Novel role for CRK adaptor proteins as essential components of SRC/FAK signaling for epithelial-mesenchymal transition and colorectal cancer aggressiveness.
Franke FC; Slusarenko BO; Engleitner T; Johannes W; Laschinger M; Rad R; Nitsche U; Janssen KP
Int J Cancer; 2020 Sep; 147(6):1715-1731. PubMed ID: 32147820
[TBL] [Abstract][Full Text] [Related]
37. The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K/AKT signaling.
Wu DM; Zhang T; Liu YB; Deng SH; Han R; Liu T; Li J; Xu Y
Cell Death Dis; 2019 Apr; 10(5):349. PubMed ID: 31024010
[TBL] [Abstract][Full Text] [Related]
38. Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer.
Liu M; Zhang Y; Yang J; Zhan H; Zhou Z; Jiang Y; Shi X; Fan X; Zhang J; Luo W; Fung KA; Xu C; Bronze MS; Houchen CW; Li M
Gastroenterology; 2021 Apr; 160(5):1771-1783.e1. PubMed ID: 33421513
[TBL] [Abstract][Full Text] [Related]
39. ZEB1-regulated inflammatory phenotype in breast cancer cells.
Katsura A; Tamura Y; Hokari S; Harada M; Morikawa M; Sakurai T; Takahashi K; Mizutani A; Nishida J; Yokoyama Y; Morishita Y; Murakami T; Ehata S; Miyazono K; Koinuma D
Mol Oncol; 2017 Sep; 11(9):1241-1262. PubMed ID: 28618162
[TBL] [Abstract][Full Text] [Related]
40. The expression level changes of microRNAs 200a/205 in the development of invasive properties in gastric cancer cells through epithelial-mesenchymal transition.
Mirzaei S; Baghaei K; Parivar K; Hashemi M; Asadzadeh Aghdaei H
Eur J Pharmacol; 2019 Aug; 857():172426. PubMed ID: 31150646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]